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1. INTRODUCTION 
Since its introduction in 1991,1 laparoscopic splenectomy has been considered the gold standard 
in spleen surgery, and the advantages of this technique over open surgery are indisputable. 
Although operative times are longer for LS than OS, LS is associated with a significant 
reduction in splenectomy-related morbidity, primarily as a function of fewer pulmonary, 
wound, and infectious complications and a shorter postoperative hospital stay.2,3 
Only a limited number of studies are available in Hungarian literature on patient population.4,5 
The laparoscopic technique for splenectomy was initiated in the Department of Surgery, 
University of Szeged in 1994 and since then our working group has gained one of the greatest 
experience in this field in Hungary. 
Although initially the usability of the laparoscopic technique was believed to be limited in cases 
of enlarged spleens, the safety of the method has also been shown in spleens of extreme size.6 
As the laparoscopic procedure has become widely used in the case of extreme-sized spleens as 
well, the difficulty of retrieving specimens sometimes weighing more than 2000 grams has been 
encountered. The usual practice is to place the specimen in an Endobag and retrieve it through 
one of the port sites with morcellation. In the case of hand-assisted laparoscopic splenectomy 
(HALS), it is obvious to retrieve the specimen through the hand port site. Besides these 
procedures, the retrieval of the specimen through a Pfannenstiel incision is also known.7 Based 
on literature data, besides spleen size, it is the learning curve that has a crucial impact on 
splenectomy results.8,9 
The most common indication for splenectomy is idiopathic thrombocytopenic purpura (ITP). 
With regard to the immunological mechanism of ITP, first-line standard therapy consists of 
corticosteroids and intravenous immunoglobulins. If patients do not respond to the first 
treatment, or if the disease responds to the treatment, but continuous therapy is required, the 
disorder is called refractory ITP and the administration of a second-line therapy is indicated. 
This treatment may consist of rituximab, TPO receptor agonists and splenectomy. Of these three 
treatment options, splenectomy provides the best and longest-lasting results (a response rate of 
approximately 80% and 60% for 5-10 years).10 
The laparoscopic approach has been an acceptable surgical method in the treatment of ITP for 
decades due to its numerous advantages. Haematological outcomes of this method are similar 
to those of conventional splenectomy.11,12 
However, only limited publications are available on the long-term results of splenectomy using 
standardized definitions and outcome criteria.13,14 
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Furthermore, with regard to the fact that splenectomy is not effective immediately in 15-25% 
of cases and that relapse occurs among 1/3 of patients, it is important to determine predictive 
factors to avoid unnecessary surgeries and to plan the therapy. Several hypothetical factors have 
been examined in predicting the outcome of splenectomy. Literature data are available on the 
predictive value of age, response to steroid therapy, perioperative platelet count and 
characteristics of platelet sequestration.15 
2. OBJECTIVES 
(i) Compare the short- and mid-term follow-up results on patients who underwent 
splenectomy with the conventional and the minimally invasive surgical method (Study I). 
(ii) Analyze the perioperative results of patients who underwent laparoscopic 
splenectomy related to spleen size, learning curve or specimen extraction method (Study II). 
(iii) Study the effect of Pfannenstiel incision in cases of extremely large spleens (Study 
III). 
(iv) Analyze the safety of splenectomy for ITP and determine which perioperative 
parameters predicted long-term results using evidence-based guidelines (Study IV.). 
3. PATIENTS AND METHODS 
3.1. Patients 
Patients who had undergone laparoscopic splenectomy or open splenectomy between 1 January 
2002 and 1 January 2015 were involved in our investigation. 
Study I: Between January 1, 2002 and December 1, 2011 141 splenectomy were performed, 
124 were scheduled and 17 were urgent surgeries. Excluding the acute and extended surgeries, 
54 laparoscopic splenectomies (n = 39 women, n = 15 men) and 30 open splenectomies (n = 17 
women, n = 13 men) were compared. The mean age of the patients was 40 (14-74) years in the 
laparoscopy group and 63 (28-79) years in the open surgery group. 
Study II: Between January 1, 2002 and December 31, 2013, 70 LS procedures were performed 
at the Department of Surgery, University of Szeged, Hungary. The male-to-female ratio of the 
70 patients was 19 to 51, and the mean age was 42.6 years (14-74). Based on the weight of the 
removed spleens, patients were divided into three groups: Group 1: <350 g (n = 42), Group 2: 
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350 to 1000 g (n = 19), Group 3: >1000 g (n = 9). The specimen was retrieved with morcellation 
through the lateral port site and the extremely large spleens were retrieved through a 
Pfannenstiel incision. 
Study III: Between January 1, 2002 and September 30, 2014, 74 LS procedures were performed 
at our department. The specimen was retrieved with morcellation in a conventional manner 
through the lateral port site in 56 cases, whereas in 12 cases, the large spleen was retrieved 
through a 10-12--cm-long Pfannenstiel incision. We analyzed the effect of the Pfannenstiel 
incision in those 11 patients who had a specimen exceeding 1000 g. 
Study IV: From January 1, 2002, to January 1, 2015, 40 splenectomies were performed for ITP. 
The patients had been treated in the Hematology Department, and the surgical indication was 
made on the basis of the hematology specialist’s report. All the patients received corticosteroid 
therapy before surgery, and splenectomy was performed in steroid-refractory or steroid-
dependent cases. Azathioprine or intravenous immunoglobulin (IVIG) therapy was 
administered to 10 patients before surgery, as well. The female-to-male ratio was 28:12. The 
mean age of the patients was 46.62 ± 17.48 years, ITP was diagnosed at an average age of 43 
years, and the surgery was performed after an average of 25.1 ± 5.73 months after the diagnosis. 
The mean duration of the follow-up was 10.9 ± 6.9 years. 
3.2. Surgery 
Preoperative investigation (ultrasound, CT scan – Figure 1) is recommended for obtaining 
information on spleen size and volume as well as the presence of accessory splenic tissue.16 
Vaccination against Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus 
influenzae were performed in each case. The surgical interventions were performed with 
antibiotic protection and a close monitoring of the platelet count. The patients received 
prophylactic low-molecular-weight heparin (LMWH) in the peri- and postoperative period (for 
30 days after discharge).  
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Figure 1: CT scan with splenomegaly 
The laparoscopic procedures were performed in a 30° lateral decubitus position with the 
“anterolateral, hanging spleen” technique according to Delaitre and Maignein.1 Trocars were 
inserted subcostally in a distance of 15 cm. (Figure 2) 
  
Figure 2: Patient positioning and trocar placement for laparoscopic splenectomy. 
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For the control of the vessels in the splenic hilum, the Endo GIA stapler was used in the learning 
period until 2006, which was later replaced with individual vessel dissection and Hem-o-lok 
clip ligation.17 The dissection of the hilum, similarly to the method of Tan, was performed from 
anterior to posterior and from inferior to superior directions, which made the identification of 
the vessels and the pancreas easy, and with which the risk of pancreatic injury could be 
minimized. (Figure 3) If the patient requires platelet transfusion, it should be administered after 
the ligation of the splenic artery. At the end of each surgery, a drain was left in place, which 
was removed on the second postoperative day. 
 
Figure 3: Steps in the LS: (A) exploration of the splenic hilum, (B) clipping of the splenic artery, (C) clipping of 
the splenic vein, and (D) removal of the specimen retrieval container 
Removing the extremely enlarged spleen from the abdominal cavity is a common technical 
problem. The specimen is usually retrieved after placing it in an Endobag through the lateral 
port site with morcellation. In the case of massive splenomegaly, when the spleen weight is 
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1000-2000 grams, this method is often infeasible, because the spleen size is larger than the 
maximum capacity of the EndoBag. According to the literature, in this case the splenic 
extraction was performed by specimen fragmentation in the abdominal cavity (risk of splenosis) 
or by a laparotomy. To solve this problem our team has been removing the specimen via a 
Pfannenstiel incision since 2009. (Figure 4) 
 
Figure 4: The Pfannenstiel incision 
In cases involving the conventional method, a left subcostal laparotomy was used to perform 
the splenectomy. The first step was the transection of the ligamentous attachments, including 
the splenophrenic ligament at the superior pole and the splenocolic and splenorenal ligaments 
at the inferior pole. Dissection was carried out at the hilum in close proximity to the spleen to 
avoid injury to the pancreas. Individual ligation of the splenic artery or arterial branches and 
the splenic vein or venous branches is generally preferable. After removal of the spleen, 
hemostasis was obtained and confirmed in a systematic fashion through careful inspection of 
the left subphrenic area, the greater curvature of the stomach, and the short gastric vessel area 
as well as the splenic hilum.  
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3.3. Conception 
We evaluated the indications for surgery, the duration of surgery, the conversion rate, the re-
operation rate, the time to bowel function recovery, the length of hospital stay, and the weight 
of the removed specimens. 
In Study I the results of open and laparoscopic splenectomy were compared. 
In Study II the results of the patient who underwent laparoscopic splenectomy were analyzed 
according to four aspects. 
(i) First, the role of the learning period was investigated. The learning curve, in 
accordance with literature data, was defined as 20 surgeries.8,9 
(ii) The effect of using a stapler vs. clips for controlling the vessels in the hilum on 
our results was evaluated. 
(iii) Furthermore, the role of spleen size was assessed dividing the patients into three 
groups based on spleen weight determined during the histological examination of the 
specimen: Group 1 consisted of patients with a spleen weight of less than 350 g, Group 2 
included those with a spleen weight between 350 and 1000 g, whereas Group 3 was formed 
by those with a spleen weighing more than 1000 g. 
(iv.) Finally, the role of the specimen retrieval method (Endobag + morcellation vs. 
Pfannenstiel incision) was investigated. 
In Study III the use of the Pfannenstiel incision was reviewed in the laparoscopic removal of 
extremely large spleens (specimen >1000 g) 
In Study IV ITP patients’ data were analyzed in aspects of haematological response to 
splenectomy. In accordance with the 2009 guidelines issued by the International Working 
Group18 and the evidence-based guidelines issued by the American Society of Hematology in 
2011,19 response was defined as platelet count over 100 x 109/l (complete response (CR)) and 
at least a two-fold increase compared to the baseline value was considered to be a response (R) 
for a platelet count between 30 and 100 x 109/l. Non-response (NR) or lack of response was 
defined as the platelet count not increasing over 30 x 109/l or not reaching a two-fold increase 
compared to the baseline value, or if these changes did not occur within 30 days.  
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Patients were considered to be stable responders if the response was maintained during the 
follow-up, no additional therapy was required and there was no bleeding complication requiring 
hospitalization after splenectomy. The case was determined to be refractory ITP or loss of 
response if any thrombocytopenic event occurred with a platelet count lower than 100 x 109/l 
in a previous responder patient (CR), if the platelet count was below 30 x 109/l, or if the platelet 
count was lower than twice the baseline value (R). Spontaneous bleeding or restarting medical 
therapy was regarded as a loss of response as well. 
Finally, the predictive value of pre- and perioperative parameters was analysed for long-term 
results (CR, R, NR and loss of response). 
3.4. Statistics 
The t-test and one-way analysis of variance were used to compare the mean values, as well as 
the Mann-Whitney and Kruskal-Wallis tests in cases of non-normality. Categorical data were 
analysed by using chi-square and Fisher’s exact tests. The normal distribution of samples was 
assessed with the Kolmogorov-Smirnov test. SPSS version 15.0 (© 2007 SPSS Inc.) was 
employed for the statistical analysis.  
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4. RESULTS 
4.1. Comparison of the conventional and the minimally invasive surgical method on 
patients who underwent splenectomy (Study I) 
4.1.1. Indications 
The indications of OS and LS are represented in figure 5 and 6. 
 
Figure 5: The indications of OS 
 
Figure 6: The indications of LS  
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4.1.2. Analysis of different types of surgical methods for splenectomises 
From the aspect of the duration of surgery, there was no significant difference between the open 
and the laparoscopic method (Table 1). 
 Laparoscopy (n = 54)  
Open surgery (n = 
30) 
p 
Duration of surgery (min) 133 (80-220) 122 (65-180) P = 0.074 
Reoperation 1 (1.9 %) 2 (6 %) P = 0.718 
Table 1: Results of LS and OS 
Conversion from laparoscopy to open surgery was required in 4 cases (7.4%), because of 
massive bleeding. 
4.1.3. Postoperative results 
There were no deaths in the perioperative period in either group. In cases of laparoscopic 
procedures bowel motility recovered earlier and hospital stay was shorter (Table 2). 
 
Laparoscopy (n = 54) Open surgery (n = 30)  
Hospital stay (days) 5.2 8.17* p < 0.001 
Time to recovery of bowel 
function (days) 
2.4 3.4* p = 0.002 
Need for blood/ 
thrombocyte transfusion 
(patients) 
18 / 23 16 / 10 
 
Table 2. Immediate postoperative results in the laparoscopic and open surgery groups 
4.2. Analysis of the perioperative results of patients who underwent laparoscopic 
splenectomy related to spleen size, learning curve or specimen extraction method (Study 
II) 
4.2.1. Indications 
The indication for surgery, similarly to literature data, was idiopathic thrombocytopenic 
purpura (ITP) in more than 50% of the cases (in 37 cases). Furthermore, the surgery was 
performed because of congenital spherocytosis in 11 cases (15.7%), lymphoma in 11 cases 
(15.7%), autoimmune hemolytic anemia (AIHA) in 4 cases (5.7%) and splenic cyst in 2 cases 
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(2.9%). Surgery was indicated because of melanoma metastasis, sarcoidosis, chronic renal 
failure, hemosiderosis and malignant mast cell tumor in 1 case each (1.4%) 
University of 
Szeged (2013) ITP 
Cong. 
spher. 
Non-Hodgkin 
lymphoma 
Hodgkin 
lymphoma 
AIHA Cyst Other 
n = 70 
37 
(52.9%) 
11 
(15.7%) 
7 
(10%) 
4 
(5.7%) 
4 
(5.7%) 
2 
(2.9%) 
5 
(7.1%) 
Table 3. Indications for surgery 
4.2.2. Surgical Procedures 
The mean duration of surgery was 122 ± 154 minutes with a mean duration by spleen size of 
117 minutes in Group 1, 128 minutes in Group 2 and 134 minutes in Group 3. The mean 
duration of surgery during the learning curve was 149 minutes, followed by a mean duration of 
111 minutes, which was a significant reduction (p = 0.002). 
Between January 2002 and December 2005, we used a vascular stapler (n = 15) for the control 
of the vessels in the splenic hilum. After that, the more cost-effective Hem-o-lok clips were 
used (n = 54), except for one case when the hilum was controlled with an Endo GIA because 
of the rupture of the splenic vein. The mean duration of surgeries with the use of a stapler was 
151 ± 105 minutes, whereas that of the surgeries with the use of clips was 114 ± 124 minutes, 
which was a significant reduction in duration (p = 0.002). 
Conversion was performed in 5 cases (7.1%), with the majority in the learning curve period 
(3 cases between 2002 and 2004). In these cases, the mean weight of the spleen was 463 ± 945 
grams and the hospital stay was prolonged and reached 7.8 days. 
Three intraoperative complications that could be resolved laparoscopically are worth 
mentioning. In one case, the already mentioned rupture of the splenic vein was treated with an 
Endo GIA stapler; one case of rupture of the left lobe of the liver and one case of diaphragmatic 
injury during the mobilization of the superior pole could be handled with laparoscopic sutures.  
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4.2.3. Postoperative results 
Reoperation was required in two cases (2.9%) because of bleeding. The weight of the spleen 
was below average (138 and 403 g) in these cases. 
Additional perioperative morbidities occurred in three cases (pneumothorax on the first 
postoperative day and, in two patients, recurrent fever after the surgery). There were no cases 
of postoperative pancreatitis or perioperative mortality. 
The mean time to bowel function recovery was two (2.57 ± 1.1) days, which showed a non-
significant relationship with the weight of the spleen (Group 1: 2.5, Group 2: 2.9, Group 3: 3.3). 
A correlation was also found in regard to the length of hospital stay: it was 5.1 ± 4.8 days on 
average (5, 5.2 and 5.4 days per group, respectively). The length of hospital stay was 
significantly reduced after the learning curve (6.15 vs. 4.7; p = 0.013). 
4.2.4. The effects of spleen size, learning curve and specimen retrieval method 
Based on the histological results, the mean weight of the spleens removed laparoscopically was 
450 ± 1945 grams. Spleens considered to be of normal size (<350 g) were removed in 42 cases 
(Group 1), spleens weighing between 350 and 1000 grams in 19 cases (Group 2) and spleens 
over 1000 grams in 9 cases (Group 3). (Table 4) 
 
Group 1: 
<350 g 
(n = 42) 
mean ± SD 
Group 2: 
350 to 1000 g 
(n = 19) 
mean ± SD 
Group 3: 
1000 g< 
(n = 9) 
mean ± SD 
P1 value P2 value 
Duration of surgery 
(minutes) 
117 ± 67 128 ± 74 134 ± 59 0.258 0.374 
Conversion 3 (7.1%) 1(5.3%) 1 (11.1%) 0.479 0.258 
Reoperation 1 (2.4%) 1 (5.3%) 0 0.145 0.489 
Hospital stay (days) 5 ± 4 5.2 ± 5 5.4 ± 4 0.846 0.661 
Time to bowel function 
recovery (days) 
2.5 ± 3 2.9 ± 2 3.3 ± 3 0.452 0.207 
Pfannenstiel incision 2 (4.7%) 4 (21%) 5 (55.6%) 0.845 0.274 
Specimen weight (g) 160 ± 159 578 ± 575 1494 ± 1220 - - 
P1 value = comparison between Group 1 and Group 2; P2 value = comparison between Group 1 and Group 3 
Table 4. LS results by weight of the specimen  
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The importance of experience is demonstrated by the fact that whereas the mean weight of the 
spleens removed during the first 20 surgeries defined in the literature as the learning curve was 
208 grams, it was 519 grams afterwards (p = 0.02). We removed the first spleen weighing more 
than 1000 g laparoscopically in 2008. (Table 5) 
 
Learning curve After the learning curve 
P value (n = 20) 
mean ± SD 
(n = 50) 
mean ± SD 
Duration of surgery 
(minutes) 
149 ± 95 111 ± 65 0.002* 
Stapler vs. clip 15 vs. 5 1 vs. 49 - 
Conversion 3 (15%) 2 (4%) 0.125 
Reoperation 1 (5%) 1 (2%) 0.795 
Hospital stay (days) 6.15 ± 5 4.7 ± 4 0.013* 
Time to bowel function 
recovery (days) 
2.5 ± 3 2.59 ± 2 0.674 
Pfannenstiel incision 0 11 (22 %) - 
Specimen weight (g) 208 ± 256 519 ± 717 0.02* 
Table 5. LS results by learning curve (*: p < 0.05) 
As mentioned previously, the retrieval of extremely large spleens was performed through an 8 
to 10 cm Pfannenstiel incision without morcellation in 11 cases after 2009 (Table 6). The 
introduction of this procedure was required because placing the enormous spleens removed 
during the LS (weighing 1000 to 2000 grams based on histological findings) in a bag 
intraabdominally and retrieving them with morcellation would have been technically difficult 
and time-consuming because of the extreme size. Because of the risk of splenosis, we did not 
perform morcellation without placing the specimen in a bag. In these cases, the mean weight of 
the spleen was 1032 ± 534 grams with a weight over 2000 grams in two cases. 
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with Pfannenstiel 
incision 
(n = 7) 
mean ± SD 
without Pfannenstiel 
incision 
(n = 47) 
mean ± SD 
P value 
Duration of surgery 
(minutes) 
108 ± 62 125 ±73 0.05* 
Hospital stay (days) 4.7 ± 3 5.2 ± 4 0.178 
Time to bowel function 
recovery (days) 
3.2 ± 2 2.5 ± 3 0.394 
Specimen weight (g) 1032 ± 534 338 ± 245 0.0001* 
Table 6. LS results by Pfannenstiel incision (*: p < 0.05) 
The mean duration of surgery was 108 ± 62 minutes, the mean time to bowel function recovery 
was 3.2 ± 2 days and the mean length of hospital stay was 4.7 ± 3 days. Based on the above 
data, the results of the cases with retrieval through a Pfannenstiel incision were not worse than 
those of the purely laparoscopic group; on the contrary, these interventions resulted in a shorter 
duration of surgery (108 vs. 125, p = 0.05) and hospital stay (4.7 vs. 5.2, p = 0.178), although 
the time to bowel function recovery was reasonably (lower abdominal laparotomy) longer (3.2 
vs. 2.5, p = 0.394). Additional factors are that better histological assessment can be performed 
on the intact specimen, and the Pfannenstiel incision is considered to be an acceptable cosmetic 
alternative (as opposed to the left subcostal or upper midline laparotomy). 
4.3. Study on the effect of Pfannenstiel incision in cases of extremely large spleens (Study 
III) 
Table 7 shows the effect of the Pfannenstiel incision in the group of patients with a specimen 
weighing more than 1000 g (n = 11, 2 conversion). There was no significant difference between 
the two removal methods. 
  
with Pfannenstiel 
incision 
(n = 5) 
mean ± SD 
without Pfannenstiel 
incision 
(n = 4) 
mean ±SD 
P value 
Duration of surgery (minutes) 121 ± 39 150 ± 47 0.31 
Hospital stay (days) 5 ± 1.3 6.5 ± 2.5 0.32 
Specimen weight (g) 1644 ± 613 1225 ± 209 0.182 
Table 7. LS results by Pfannenstiel incision in cases of extremely large (>1000 g) spleens (*: p < 0.05) 
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4.4. Analysis of the safety of splenectomy for ITP and determining which perioperative 
parameters predicted long-term results using evidence-based guidelines (Study IV) 
4.4.1. Previous treatment 
In all cases, the first-line therapy of ITP was steroid therapy. 23 cases (57.5%) were steroid-
refractory and 17 (42.5%) were steroid-dependent. After this, 30 patients underwent 
splenectomy as second-line therapy. In 7 cases, azathioprine was administered and 3 patients 
received IVIG therapy as second-line therapy, followed by splenectomy. 
4.4.2. Results of surgery 
In 4 of the 40 cases (10%), conversion was required and, finally, open surgery was performed. 
There was no perioperative mortality. Two patients (5%) required reoperation for bleeding. The 
average duration of surgery was 113.5 ± 62.71 minutes. 3 of the 4 conversions were required 
before 2004 during the learning curve (LS was introduced at our clinic in 2000). The literature 
defines the learning curve as 20 surgeries for laparoscopic splenectomy,13, 14 which was 
exceeded in 2006, taking into account LS performed with other indications. After this, the 
average duration of surgeries decreased significantly from 132 to 104 minutes (p = 0.032). The 
average weight of the specimens removed was 174 ± 89.6 g. The average duration of 
postoperative care was 5.44 ± 2.84 days. Perioperative morbidity occurred in 4 cases, 1 patient 
suffered from pneumothorax, 1 experienced superficial thrombophlebitis and 2 had recurring 
fever. 
4.4.3. Short- and long-term haematological results of splenectomy for ITP 
The average preoperative platelet count was 66.7 ± 47.84 x 109/l. In cases requiring the 
administration of platelet suspension (27), it was administered during the surgery after clipping 
the vessels of the spleen. On the 3rd postoperative day, the average platelet count was 
148.4 ± 93.7 x 109/l. Based on the postoperative platelet counts, complete response (CR) 
occurred in 28 (70%) cases and a response (R) developed in 5 (12.5%). A total of 82.5% of the 
patients responded to splenectomy in accordance with the guidelines. 7 (17.5%) non-responder 
(NR) cases occurred. (Table 8) 
Patient follow-up lasted an average of 10.9 ± 6.9 years. During this time, 2 patients died 5 and 
7 years after the splenectomy, respectively (cause of death was a cardiac event in the case of an 
84-year-old patient and neoplasm caused the death of a 56-year-old patient). During the follow-
up, 21 (63.6%) of the responders (CR + R = 33) had a permanent response. Patients with a CR 
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experienced a permanent response in 20/28 cases (71%), while a permanent response was 
achieved in 1 of 5 cases (20%) among the R patients. Relapse occurred 12.5 ± 7.3 months after 
the splenectomy on average. The relapse rate was significantly higher in the R group compared 
with CR patients (80% vs. 28.6%). R cases experienced a relapse sooner compared with the CR 
patients (9.7 vs. 18.6 months, p < 0.001). 
The 12 patients with relapse and the 7 non-responder patients underwent steroid, TPO receptor 
agonist (romiplostim and eltrombopag), azathioprine or IVIG therapy as further treatment. 
 
All responses 
Non-
responses 
Complete responses 
(PLT > 100 x 109/l) 
Partial responses 
(PLT 30 - 100 x 109/l) 
 
Number of patients (n = 40) 
(%) 
28 (70%) 5 (12.5%) 7 (17.5%) 
Age (years) 42.79 ± 13.24 49.2 ± 18.32 
60.14 ± 24.2
1 
Gender (f/m) 18/10 5/0 5/2 
Splenic weight (g) 160.13 ± 12.47 206.25 ± 10.21 229 ± 9.62 
Postoperative rise of 
thrombocyte count (103/µl) 
122,5 ± 34.2 50.8 ± 11.5 8 ± 9.62 
Relapse rate (%) 8/28 (28.6%) 4/5 (80%)  
Median time to relapse 
(months) 
18.6 9.7  
Table 8. General results for splenectomy in ITP patients  
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4.4.4. Predictive factors for short- and long-term response 
Based on the results above, we examined which known perioperative factors and parameters 
predicted short- and long-term success (Table 9). 
All the patients operated on as steroid-dependent (n = 17) were CR, while patients operated on 
because they were steroid-refractory were classified as CR (11), R (5) and NR (7). From a 
different perspective, all R (5) and NR (7) patients fell into the preoperative steroid-refractory 
group. Significantly more NR patients were in the steroid-refractory group (0/17 vs 7/23; p = 
0.027). 
Long-term results suggest that among the steroid-dependent patients (n = 17) 12 had a persistent 
response (70.6%), while 9 out of 16 patients (56.3%) in the steroid-refractory group were 
persistent responders (NS). 
The average age of the CR group was 42.79 ± 13.24, that of the R group 49.2 ± 18.32 and that 
of the NR group was 60.14 ± 24.21 years. Among the patients below the age of 50 years (n = 
22), 17 were CR, 3 were R and 2 were NR. Among the patients over the age of 50 years (n = 
18), 11 were CR, 2 were R and 5 were NR. Therefore, in the younger group, 9% of the patients 
did not develop a response; this rate was 28% among the patients in the older group 
(2/22 vs. 5/18) (p = 0.023). 
Long-term follow-up showed that the average age of persistent responders was 42.6 ± 16.5 and 
that of patients with relapse was 45.75 ± 21.3 years. Among the patients below the age of 50 
years, 14 out of 20 patients were persistent responders (70%), while this rate was 7 out of 13 
among older patients (53.8%) (NS). 
  
24 
 
 
All responses 
Non-
responses 
Complete responses 
(PLT > 100 x 109/l) 
(n = 28) 
Partial responses 
(PLT 30-100 x 109/l) 
(n = 5) (n = 7) 
Preoperative 
steroid 
-dependent 
(n = 17) 
17 (100%) 0 0 
-refractory 
(n = 23) 
11 (47.8%) 5 (21.7%) 7 (30.4%) 
Age 
<50 years 
(n = 22) 
17 (77.3%) 3 (13.6%) 2 (9%) 
>50 years 
(n = 18) 
11 (61%) 2 (11%) 5 (27.8%) 
Preoperative 
platelet count 
<30 x 109/l 
(n = 16) 
7 (43.75%) 5 (31.25%) 4 (25%) 
>30 x 109/l 
(n = 24) 
21 (87.5%) 0 3 (12.5%) 
Splenectomy 
as a… 
…second-
line therapy 
(n = 30) 
22 (73.3%) 3 (10%) 5 (16.7%) 
…third-line 
therapy 
(n = 10) 
6 (60%) 2 (20%) 2 (20%) 
Table 9. Possibly predictive factors 
Of the patients whose preoperative platelet count was below 30 x 109/l (n = 16), 7 were in the 
CR group (43.75%), 5 were in the R group (31.25%) and 4 were in the NR group (25%). Among 
the patients with a platelet count over 30 x 109/l (n = 24), 21 were in the CR group (87.5%) and 
3 were in the NR group (12.5 %) (NS). 
Of the 10 patients who had undergone splenectomy as a third- and not a second-line therapy 
(after azathioprine or IVIG therapy), the surgery was performed after an average of 17.75 ± 3.43 
months following the diagnosis, which is surprisingly shorter compared with the average value 
of all the patients. Of these 10 patients, 6 were CR, 2 were R and 2 were NR (NS).  
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In summary, response to first-line steroid therapy (dependency) (p = 0.027) and younger age (p 
= 0.023) proved to be more effective in predicting short-term efficacy of splenectomy based on 
logistic regression analysis (Table 10). 
Factor OR 95% CI p value 
Preoperative steroids 1.265 1.063-1.496 0.027 
Age 1.359 1.0370-1.771 0.023 
Table 10. Results of logistic regression analysis in the NR subgroups 
None of the parameters examined and listed in Table 8 predicted long-term haematological 
outcomes, although we confirmed that the extent of the immediate response was a good 
predictor of long-term results, which is often described in the literature as well: 71% permanent 
response for CR and 20% for R (p < 0.001).  
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5. DISCUSSION 
5.1. A history of splenectomy 
For millennia, the spleen has been considered a fascinating and mysterious organ with more 
functions than any other. It has long been an organ of interest. Most famous scientists had their 
own theory of its function. According to Plato, the spleen was created in order “to maintain the 
liver bright and pure”. In ancient Greece, Hippocrates, in his Aphorisms, described with 
remarkable accuracy the anatomy of the spleen, also recognizing its indispensable role in life, 
since it produced the “black bile”, one of the four vital humors. However, there were some who 
considered the spleen a simple counterbalance, “to balance the left part of the body with the 
right”, but many considered it “a useless Organ, to be eliminated!”.20 
During the centuries, there were more and less successful attempts to perform splenectomies, 
especially because of traumatic causes. The first description of a traumatic hernia of the spleen 
is attributed to Ambroise Paré de Laval (1545). However, besides traumatic causes, in 16th 
century they suspected a benign effect of splenectomy in hematological diseases. Fioravanti 
reports that splenectomy was performed in Italy in 1549 by the old Neapolitan surgeon Adriano 
Zaccaria on a 24-year-old lady with malarial splenomegaly: “The spleen weighed 1340 grams; 
the recovery was 24 days”. 
The first splenectomy for a tumorous spleen was performed by Quittembaum in 1826: “an organ 
of 6 libra of weight in an ascitic woman of 22 years”. Franzolini, in Italy, reported in 1881: “I 
extirpated the organ in a woman of 22 years with aplastic anemia and the medical examination, 
practised many months after, showed a normal relationship between leucocytes and red 
corpuscles”.21,22 
Between 1905 and 1926, Lord Berkeley Moynihan, who would be president of the Royal 
College of Surgeons of England from 1926 to 1930, published four editions of his book 
Abdominal operations, defining medical indications for splenectomy that ranged from leukemia 
to Hodgkin’s disease, from pernicious anemia to Gaucher’s disease.23 With improvements in 
anesthesia, surgical techniques, hematology and oncology the mortality and morbidity have 
decreased. Recently, laparoscopic resection and partial resection of the spleen have become 
fairly commonplace. The technique was first described in 1992 and has become a well-accepted 
procedure.1, 24 In fact, at the present time, laparoscopic splenectomy is the “gold standard” for 
the surgical treatment of immune thrombocytopenia purpura.25  
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5.2. Open vs. laparoscopic splenectomy (Study I) 
The laparoscopic splenectomy was first described in 1992 by Delaitre and Maignien. Since its 
introduction, LS has become the gold standard because of its numerous known advantages over 
open surgery (OS). 
The advantages of the minimally invasive technique generally include a shorter hospital stay, 
less postoperative pain, a shorter time for recovery of the bowel function, fewer incisional 
hernias and a better cosmetic result, but it has the disadvantage of a longer duration of surgery. 
Laparoscopic splenectomy is indicated for most benign and malignant hematologic diseases 
independently of the patient’s age and body weight. The expert panel still considers portal 
hypertension and major medical comorbidities as contraindications to LS.16 Several systematic 
reviews have confirmed the advantages of the LS over the open technique, e.g. the meta-
analyses of Winslow2 and Bay,3 which show a uniformly lower complication rate, shorter 
hospital stay, reduced blood loss and longer duration of surgery in a population of about 3000 
patients. Cheng, in a comprehensive meta-analysis based on a 15-year literature, found that, 
technically, LS should be recommended as a prior remedy with its advantage of rapid recovery 
and minimal physical damage, in addition to its comparable surgical efficacy compared to that 
of open manipulation.26 
Similarly, in our study, LS was found to be not significantly longer than OS (133 vs. 122 
minutes, p = 0,074). In cases of laparoscopic procedures bowel motility recovered earlier (2 vs. 
3 days, p = 0,002) and hospital stay was significantly shorter (5 vs. 8 days, p < 0,001). 
5.3. The effect of the learning curve (Study II) 
One of the most important factors in our study was the experience of the team. Several 
publications in the literature focus on this topic: Cusick has investigated the importance of the 
learning curve after 49 cases of splenectomy in children. He found significant reduction in the 
duration of surgery, intraoperative blood loss and hospital costs when comparing the results of 
the first and last 10 patients and established the limit, after which the duration of surgery and 
the costs were reduced owing to the experience in 20 surgeries.8 Peters et al. have defined the 
learning curve studying surgeries performed because of ITP. After sorting 50 surgeries into 
groups of ten in chronological order, they have concluded that the duration of surgery of patients 
in the first 2 groups was significantly longer than that in groups 3, 4 and 5. No difference was 
found in blood loss, hospital stay and time to oral feeding and the learning curve was defined 
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as performing at least 20 surgeries.9 In our study, the duration of surgery and the length of 
hospital stay significantly decreased after the learning curve. 
For the control of the vessels in the splenic hilum, we initially used a vascular stapler, and after 
2006, we employed individual vessel dissection and clips, similarly to the method described by 
Tan in their paper published in 2013.17 Similarly to Tan, we found the method to be safe, 
especially in the case of splenomegaly when the positioning of the stapler would be difficult 
because of the reduced space. There are papers about managing the splenic hilum with a 
LigaSure instrument or a Harmonic scalpel only,27,28 but this method was not employed by our 
work group. 
5.3. Special issue –large spleens  
The publications related to the topic uniformly consider it a standardized, safe method in the 
case of a normal-sized spleen. In the case of massive splenomegaly, however, the opinion is 
divided. Targorana et al. have found a correlation between spleen weight and conversion rate: 
compared to the mean rate of 6.7%, a conversion rate of 25% was observed in the case of 
massive splenomegaly.29 With a conversion rate of 13.3%, Sapucahy et al. have recommended 
the laparoscopic procedure for smaller spleens.30 Poulin does not recommend the laparoscopic 
method over a craniocaudal diameter of 20 cm and a weight over 1000 grams.31 The already 
mentioned paper of Bai et al., summarizing 39 trials and 1,540 patients subjected to 
laparoscopic splenectomy, defines massive splenomegaly as a spleen weight over 1 kg, and 
finds longer duration of surgery, higher conversion rate, higher blood loss, longer hospital stay 
and an increased rate of perioperative complications, each of which is considered to be 
preventable in the case of an experienced surgeon.3 Furthermore, several recent publications 
have supported that LS is a safer and more effective method than OS also in the case of massive 
splenomegaly.32,33,34 These results were also supported by a systematic review performed on 
1,500 patients.6 
In the case of massive splenomegaly, the main complication is severe bleeding, which is also 
the main cause of conversions and re-operations. Different sources estimate the conversion rate 
to be in the range of 6 to 36%.35,36,37 In our study it was 7.1%, and conversions were performed 
mainly in the learning curve period. In our study, the large spleen had no effect on the 
conversion rate and, although there was a trend of increase in duration of surgery and hospital 
stay in the case of larger spleens, there was no significant difference between the groups. 
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Several authors have found that the difficulties related to larger spleen size can be resolved with 
the use of hand-assisted laparoscopic splenectomy (HALS). In a paper published in 2007, Wang 
observed a shorter duration of surgery, lower blood loss and a reduced conversion rate in the 
case of HALS compared to conventional LS.38 Similar results were presented in the case of 
complicated splenectomies (supramassive splenomegaly, portal hypertension) as well in their 
paper published in 2013.39 According to Targorana et al., the hand-assisted technique decreased 
the length of hospital stay (4 vs. 6.3 days), morbidity was lower (10% vs. 36%), and the duration 
of surgery was shorter (135 minutes vs. 177 minutes) in the case of a spleen weighing more 
than 700 grams.40 When studying the complications of laparoscopic splenectomy, Wang et al. 
observed a lower postoperative complication rate in the case of HALS (in subxiphoid position) 
compared to the purely laparoscopic group (OR: 22.311 vs. 6.713).41 
In the clinical practice guidelines of the EAES in cases of massive splenomegaly, the hand-
assisted technique should be considered to avoid conversion to open surgery and to reduce 
complication rates.16 
5.4. Retrieving enlarged spleens 
Retrieving a large-sized spleen from the abdominal cavity may also be difficult during LS. In 
general, placing the specimen in a retrieval bag and intraabdominal morcellation are 
recommended. At the end of the procedure, a thorough rinsing of the abdominal cavity with 
saline is recommended to avoid splenosis, and a color Doppler scan is to be performed within 
3 months.34,42  
The Pfannenstiel incision is a known adjunct to several types of laparoscopic surgery. There 
have been relatively few papers published on its role in the laparoscopic surgery of the spleen 
and the retrieval of the specimen, and those identify the Pfannenstiel incision rather than the 
site for insertion of the hand port.43,44 We suppose that a hand port introduced through a 
Pfannenstiel incision for left upper abdominal surgery leads to unnecessary inconveniences, 
especially in the case of a right-handed surgeon. Besides, eliminating the use of the hand port 
reduced the costs during our study. 
There is only one publication, the paper of Patle (2010) on making a Pfannenstiel incision for 
the sole purpose of retrieving the specimen after purely laparoscopic splenectomy, which 
includes 50 patients operated on due to β-thalassemia.7 The specimen was retrieved through a 
7 to 8 cm Pfannenstiel incision in 37 cases and with the extension of the umbilical port site in 
12 cases and conversion was performed in one case. In the case of retrieval through the 
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Pfannenstiel incision, similarly to our results, a significantly shorter duration of surgery was 
observed, and the procedure is considered a cosmetically acceptable alternative. 
If the specimen could not be placed in a bag because of its extreme size, our work group 
retrieved it in whole through a Pfannenstiel incision. Because of the risk of splenosis, we 
performed intraabdominal morcellation only after placing the specimen in an Endobag. It is 
especially important in the treatment of hematological malignancies of the spleen, because of 
the need of pathological characterization of malignant disease.45,46 On the other hand, in 
malignancies splenomegaly is more characteristic, therefore most malignant cases required an 
accessory incision (47% Pfannenstiel in our study) at the end of the procedure to extract the 
intact spleen. 
5.5. Splenectomy in the treatment of ITP (Study IV) 
In steroid-refractory and steroid-dependent ITP patients, splenectomy provides the best and 
most permanent results as a second-line therapy compared with medicinal therapy (TPO 
mimetics and rituximab).15,47,48 
A splenectomy exerts its effect by removing the primary site of platelet destruction and partly 
by removing an important site of antiplatelet antibody production, with the response rate 
reported at an average of 80% and the rate of permanent responders approximately 60%.13,15,49 
In a systematic review of 135 cases published in 2004, the response rate was 88% and a 
complete response was found in 66% of them, with a median follow-up duration of 28 months.12 
In a systematic review of laparoscopic splenectomies published in 2009, the conversion rate of 
the 1,223 patients examined was 5.6%, and the success rate was 72%.50 In our study, CR was 
70% (n = 28) and R occurred in 12.5% (n = 5) of the cases; that is, a total of 82.5% of the 
patients responded to splenectomy performed in accordance with the guidelines. This rate was 
not influenced by whether the splenectomy was done as a second- or third-line therapy. In 
patients treated with azathioprine or IVIG after steroid treatment, CR was achieved in 60% after 
splenectomy, R occurred in 20% after the surgery and the NR rate was 20%. These rates are 
consistent with the results found after examining all the patients; therefore, previous treatment 
did not influence the efficacy of the splenectomy. 
After a follow-up of an average of 9.92 years, 63.6% of the responder patients (CR + R = 33) 
had a permanent response (n = 21), which correlates with the known rate of one-third of patients 
showing a response initially developing a relapse later as well.12,47 
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If relapse occurs after splenectomy, based on the literature data, it takes place after  
12-48 months. After this time, it only occurs sporadically.47 Our study confirmed this result. In 
our patients, relapse developed after an average of 12.5 months and no relapse was detected 
after 47 months. 
Alternative options for second-line therapy are medications such as rituximab or TPO-RAs. 
The long-term efficacy of these therapies is less than that of splenectomy. Rituximab (a 
chimeric monoclonal antibody against CD20) has an immediate efficacy of 50-65%, although 
relapse occurs frequently; therefore, the long-term response after 12 and 24 months is only 
between 20 and 30%.51,52 
In 2015, a multicentre, randomized, double-blind, placebo-controlled study was published in 
the Lancet describing a long-term response rate for rituximab similar to that of the placebo.53 
A study published in 2016 comparing the results for splenectomy and rituximab therapy found 
splenectomy to be more effective (the 30-month primary outcome-free survival rate was  
84-86% vs. 47%, p = 0.0002).14 TPO agonists exert their effect by enhancing platelet 
production, not by modulating the immune system. TPO agonists stimulate platelet production 
of megakaryocytes. A response rate of 59–80% can be achieved with these medications, 
however, a great disadvantage of these products is that they are expensive and that permanent 
treatment is required, since withdrawal of therapy leads to the recurrence of 
thrombocytopenia.48,54,55 
With regard to the splenectomy technique, several publications are available comparing LS and 
OS. It can be concluded that LS and OS are similarly effective from a hematological point of 
view.56 Qu et al. performed open and laparoscopic splenectomies and no significant difference 
was found for relapse-free survival during a 36-month follow-up (86% vs. 91%, respectively, 
p = 0.792).13 Chater et al. reached similar results for 30-month event-free survival, with no 
difference found between LS and OS (86% vs. 84%).14 In a systematic review conducted on 47 
case series in 2004, a lower mortality rate (1% vs. 0.2%) and fewer complications (12.9% vs. 
9.6%) were observed for LS.12 The main limitation of the laparoscopic technique is 
splenomegaly, although our previous results showed that laparoscopic splenomegaly was not 
contraindicated even in the case of extreme splenomegaly (spleen weighing over 2000 grams). 
Splenomegaly causing technical difficulties is not characteristic of ITP; therefore, this limiting 
factor is not common either. 
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5.5.1. Potential predictive factors of the efficacy of splenectomy 
There are several publications about potential predictive factors that may be determined before 
splenectomy and that may be used to predict long-term results for the surgery as well. The most 
widely accepted predictive factors are younger age, steroid dependency and non-refractory 
states, as well as higher platelet count before surgery and splenic sequestration. In our study, 
no data was available for splenic sequestration, so results were analysed using the other factors. 
Our study confirmed the predictive value of younger age described in the literature.57,58,59,60 
The average age of the CR group was 42.79 ± 13.24 years, that of the R group 49.2 ± 18.32 
years and that of the NR group 60.14 ± 24.21 years. Long-term follow-up for persistent 
responders showed an average age of 42.6 ± 16.5 years and patients developing a relapse were 
45.75 ± 21.3 years old on average. The response rate for patients below the age of 50 years (n 
= 22) was 90.1% (77.3% CR and 13.6% R), while this rate was 72.2% (61.1% CR and 11.1% 
R) in patients over the age of 50 (n = 18). There were significantly more NR patients in the 
older group (p = 0.023). In addition, 70% of the patients below the age of 50 showing a response 
at first also had a permanent response, while this rate was only 53.8% in older patients. 
Shojaiefard et al. found results similar to ours; in their study, patients below the age of 52 
responded to splenectomy more positively compared to elderly patients (p < 0.01).57 Fabris et 
al. confirmed age below 40 years to be the only major predictive factor in a similar 
investigation.58 However, several opposite results are found in the literature as well: Vianelli et 
al. studied 233 patients for more than 10 years and found no link between age and response to 
splenectomy47 and, similarly, Rijcken et al. had negative results for the predictive value of age 
in their examination of 72 patients.61 
Several studies have analysed the predictive role of response to preoperative steroids.61,62,63 In 
our study, all the patients operated on as steroid-dependent (n = 17) were in the CR group, 
although all the R (5) and NR (7) patients fell into the preoperative steroid-refractory group. 
There were significantly more NR patients in the steroid-refractory group (p = 0.027). In the 
case of patients showing a persistent response (n = 21), 12 were steroid-dependent and 9 were 
steroid-refractory patients; in the loss of response group (n = 12) there were 5 steroid-dependent 
and 7 steroid-refractory patients. Rijcken,61 Aleem62 and Radaelli,63 among others, found 
response to steroids to be a predictive factor in their studies. 
Perhaps the least controversial fact is that complete response (CR) significantly predicts the 
probability of a long-term stable response.61,64 Wang et al. followed up 92 patients and found 
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the platelet count in the 3rd postoperative month to be an independent predictor of long-term 
outcome.65 Rijcken found a greater increase in platelet count in the postoperative period 
(>150,000/µl) to be a predictor of long-term response.61 Montalvo examined 150 patients and 
found an immediate response after surgery (≥150,000) to be the one-year CR predictor.66 In 
addition, Vianelli followed up 233 patents for at least 10 years and confirmed no stable 
predictors of long-term response.47 During our follow-up, we concluded the same findings. 
While results were found to be permanent in 71% of the CR patients, a permanent response 
only occurred in 20% of the patients in the partial response group. 
In the future, lifespan and sequestration studies of platelets labelled with Indium would be 
useful (if the splenic literature data shows that splenectomy is effective in 90% of cases),64,67,68 
although such data is not available in our study. 
The role of an accessory spleen in the recurrent disease is also an intensively investigated issue. 
In a review article summarizing data of 22,000 people, the overall pooled prevalence of AS was 
14.5%, while the pooled prevalence of AS in ITP patients was 16.7%. The majority of accessory 
spleens were located in the splenic hilum.69 The relapse of thrombocytopenia post-splenectomy 
can be associated with the presence of an accessory spleen.70 In our study we had limited 
information about the presence of remnant AS because of the lack of postoperative screening 
ultrasound, therefore we could not analyse this issue. 
Finally, we compared our results to the literature data and examined both (a) the number of 
published studies that used the consensus guidelines to follow patients in the long term after 
laparoscopic splenectomy since the 2011 introduction of the standardized guidelines19 and (b) 
the predictive factors in these publications. 
Xu et al. analysed 114 patients in their 2016 study, in which age and postoperative peak platelet 
count were independently associated with the response.71 Vecchio also examined patients with 
laparoscopic and open surgeries for a 2015 article and found that a higher increase of 
postoperative platelet count may be predicted in patients with a low preoperative platelet 
count.72 In the investigation by Rijcken with 72 patients (noted above), perioperative platelet 
counts were predictive factors of long-term response.61 Navez studied 82 patients in 2014, 
primarily examining the predictive value of platelet sequestration; the platelet sequestration site 
was not found to be a predictive factor, but age was.73 Montalvo reviewed data on 150 patients 
and found no predictive factors of long-term permanent response besides immediate complete 
response (response >150,000 platelets/ml during the first week).66 In the 2013 article by Wang 
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noted above, the platelet count in the 3rd postoperative month (POM 3) was a significant 
independent predictor of long-term favourable hematological outcomes.65 
In summary, literature data have been exceedingly heterogeneous with regard to predictive 
factors, even since the consensus guidelines were published. In addition, potentially prospective 
studies are necessary to determine predictive factors. Furthermore, long-term follow-up of 
patients with various imaging techniques is important to screen the accessory spleen and its 
possible role in nonresponsive and refractory ITP. 
5.5.2. Reasons against splenectomy: potential complications of splenomegaly 
With second-line medicinal therapy, the possibility of peri- or postoperative or late 
complications of splenectomy is often emphasized.47 In our study, complications were only 
observed after splenectomy in 2 cases, with the patients experiencing bleeding that required 
reoperation. No complication occurred besides reoperation due to bleeding in 5% of the 
patients, although surgery was performed with a platelet count of 5000/ml in several (3) 
patients. Several publications have analysed the safety of surgeries performed with a low 
platelet count. Cai et al. compared the results of laparoscopic splenectomy patients with a 
platelet count below 10 x 109/l (Grade 1) with those of patients operated on with a higher 
platelet count (Grade 2: 10-30 x 109/l; Grade 3: >30 x 109/l).74 Our results showed that blood 
loss or the number of complications was not significantly increased and the duration of 
hospitalization was not significantly prolonged in patients operated on with a lower platelet 
count. Wu et al. examined surgical patients with a platelet count below 20 x 109/l and found no 
difference with regard to the outcome of the surgery in a comparison of patients not receiving 
preoperative platelet transfusion and those receiving preoperative platelet transfusion.75 In our 
case, reoperation was performed on 2 patients with platelet counts of 36 x 109/l and 42 x 109/l. 
No pancreatitis, perioperative infection or suppuration occurred. Patients undergoing 
splenectomy are more susceptible to infections and vascular complications in the long term. 
Increased risk of infections is confirmed in patients undergoing splenectomy. In a Danish cohort 
study, susceptibility to infections among 3,812 patients having had splenectomy was compared 
with that of 8,310 matched non-splenectomized patients and that of 38,120 control patients. The 
risk rate for sepsis increased fourteen-fold in patients undergoing splenectomy during the first 
year compared with the general population; after one year, the risk rate decreased to four times. 
Comparing the results with those of non-splenectomized ITP patients, an increased risk rate of 
sepsis was only found during the first 90 days.76 Perioperative vaccination, patient education 
35 
 
on the risk of overwhelming sepsis and the use of antibiotic prophylaxis greatly aid in 
preventing septic complications. For instance, Vianelli et al. examined 402 patients in their 
study and did not report sepsis-related mortality.77 In our study, no sepsis-related mortality 
occurred. 
In addition to the risk of infection, other potential complications are vascular complications. 
The thrombocytopenia for ITP makes patients susceptible to thromboembolisation in 
accordance with the literature data;78 in addition, splenectomy increases the risk of venous 
thromboembolisation.79 In our study, with prophylactic LMWH administered permanently, no 
deep venous thrombosis was confirmed, only one superficial thrombophlebitis. 
In our investigation, surgery-related morbidity was not significant, and due to potential risks, 
estimation of response is very useful in considering surgery based on predictive parameters. 
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6. CONCLUSION 
(1) Our working group was the first to publish a comprehensive study with different aspects of 
the minimal invasive surgery of the spleen in Hungary. 
Based on our results, similarly to literature data, it may be established that laparoscopic 
splenectomy can be considered a surgical procedure with low morbidity after gaining the 
necessary experience. In our study, the bowel motility recovered earlier and hospital stay was 
significantly shorter after laparoscopic procedures. 
(2) Laparoscopic splenectomy is a safe method in cases of extremely large spleens. 
(3) In the case of massive splenomegaly, the Pfannenstiel incision may be a cosmetically more 
acceptable alternative for the retrieval of the spleen than the mini laparotomy performed for the 
hand port inserted in the upper abdominal region during HALS and surgical costs may also be 
reduced by restricting the use of the hand port. In addition to the above, a shorter duration of 
surgery, prevention of splenosis and an improved histological assessment of the specimen might 
be expected from the use of the Pfannenstiel incision. 
(4) Although several medications are available for second-line ITP therapy, splenectomy 
provides the longest-lasting results. Laparoscopic splenectomy is the gold standard, as it can be 
performed safely and with great efficacy in centres experienced in the technique. In our study, 
young age and a preoperative response to steroids (steroid-dependent cases) were positive 
predictors for the success of splenectomy. 
(5) In the case of an immediate complete response to splenectomy, relapse occurred 
significantly less often during long-term follow-up.  
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